| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Verrica Pharmaceuticals Inc. (VRCA) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 28 sells. VRCA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.35M | $26.75M | - | |
| CEO | 182.6K | $1.46M | - | |
| COO | 21.0K | $167.8K | - | |
| Dir | 20.0K | $159.8K | - | |
| Dir | 20.0K | $159.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2019 | Palczuk Linda78 | Chief Operating Officer | Buy | 3,000 | $10.53 | $31,590.00 | +54.5% | |
| Jan 15, 2019 | Davidson Matt | 10% Owner | Sell | 8,019 | $10.53 | $84,472.41 | - | |
| Jan 10, 2019 | Davidson Matt | 10% Owner | Sell | 15,802 | $10.87 | $171,826.96 | -0.1% | |
| Jan 7, 2019 | Manning Paul B53 | Director, 10% Owner | Buy | 47,500 | $11.17 | $530,811.18 | +0.2% | |
| Jan 7, 2019 | Stalfort Sean | Director | Buy | 9,221 | $10.45 | $96,385.98 | +1.1% | |
| Jan 7, 2019 | Davidson Matt | 10% Owner | Sell | 33,276 | $9.80 | $326,259.33 | -0.2% | |
| Jan 2, 2019 | Davidson Matt | 10% Owner | Sell | 1,000 | $8.25 | $8,248.00 | - | |
| Dec 27, 2018 | Davidson Matt | 10% Owner | Sell | 4,100 | $8.02 | $32,871.00 | - | |
| Dec 21, 2018 | Davidson Matt | 10% Owner | Sell | 12,439 | $7.35 | $91,473.67 | -0.1% | |
| Dec 18, 2018 | Davidson Matt | 10% Owner | Sell | 4,215 | $9.57 | $40,330.60 | - |